Étude pharmacoépidémiologique sur l'utilisation de fulvestrant en pratique clinique en France
- Other title
- Fulvestrant use in clinical practice in France: a pharmacoepidemiologic study (en)
- Author
- PIEDBOIS, P1 ; THOMAS-DELECOURT, F1 ; FLINOIS, A2
[1] AstraZeneca, 92844 Rueil-Malmaison, France
[2] TNS Healthcare, 138, avenue Marx-Dormoy, 92120 Montrouge, France - Source
Bulletin du cancer. 2009, Vol 96, Num 6, pp 695-702, 8 p ; ref : 24 ref
- CODEN
- BUCABS
- ISSN
- 0007-4551
- Scientific domain
- Medical oncology
- Publisher
- John Libbey Eurotext, Montrouge
- Publication country
- France
- Document type
- Article
- Language
- French
- Author keyword
- France cancer du sein fulvestrant ménopause pharmacoépidémiologie
- Keyword (fr)
- Adulte Anticancéreux Cancer du sein Cancérologie Chimiothérapie Durée Epidémiologie Fulvestrant Ménopause Régulateur négatif sélectif du récepteur des oestrogènes France Antagoniste Antihormone Antioestrogène Cancer Homme Pathologie de la glande mammaire Pathologie du sein Récepteur oestrogène Santé publique Traitement Tumeur maligne Europe
- Keyword (en)
- Adult Antineoplastic agent Breast cancer Cancerology Chemotherapy Duration Epidemiology Fulvestrant Menopause France Antagonist Antihormone Antiestrogen Cancer Human Mammary gland diseases Breast disease Estrogen receptor Public health Treatment Malignant tumor Europe
- Keyword (es)
- Adulto Anticanceroso Cáncer del pecho Cancerología Quimioterapia Duración Epidemiología Fulvestrant Menopausia Francia Antagonista Antihormona Antiestrógeno Cáncer Hombre Glándula mamaria patología Seno patología Receptor estrógeno Salud pública Tratamiento Tumor maligno Europa
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21699478
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"\u00c9tude pharmaco\u00e9pid\u00e9miologique sur l'utilisation de fulvestrant en pratique clinique en France\";s:9:\"\u0000*\u0000jtitle\";s:18:\"Bulletin du cancer\";s:9:\"\u0000*\u0000stitle\";s:12:\"Bull. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"695\";s:8:\"\u0000*\u0000epage\";s:3:\"702\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-4551\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PIEDBOIS\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:19:\"THOMAS-DELECOURT, F\";i:1;s:10:\"FLINOIS, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BUCABS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"\u00c9tude pharmaco\u00e9pid\u00e9miologique sur l'utilisation de fulvestrant en pratique clinique en France\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"\u00c9tude pharmaco\u00e9pid\u00e9miologique sur l'utilisation de fulvestrant en pratique clinique en France\";s:9:\"\u0000*\u0000jtitle\";s:18:\"Bulletin du cancer\";s:9:\"\u0000*\u0000stitle\";s:12:\"Bull. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"695\";s:8:\"\u0000*\u0000epage\";s:3:\"702\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-4551\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PIEDBOIS\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:19:\"THOMAS-DELECOURT, F\";i:1;s:10:\"FLINOIS, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BUCABS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"\u00c9tude pharmaco\u00e9pid\u00e9miologique sur l'utilisation de fulvestrant en pratique clinique en France\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"\u00c9tude pharmaco\u00e9pid\u00e9miologique sur l'utilisation de fulvestrant en pratique clinique en France\";s:9:\"\u0000*\u0000jtitle\";s:18:\"Bulletin du cancer\";s:9:\"\u0000*\u0000stitle\";s:12:\"Bull. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"695\";s:8:\"\u0000*\u0000epage\";s:3:\"702\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-4551\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PIEDBOIS\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:19:\"THOMAS-DELECOURT, F\";i:1;s:10:\"FLINOIS, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BUCABS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"\u00c9tude pharmaco\u00e9pid\u00e9miologique sur l'utilisation de fulvestrant en pratique clinique en France\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"\u00c9tude pharmaco\u00e9pid\u00e9miologique sur l'utilisation de fulvestrant en pratique clinique en France\";s:9:\"\u0000*\u0000jtitle\";s:18:\"Bulletin du cancer\";s:9:\"\u0000*\u0000stitle\";s:12:\"Bull. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"695\";s:8:\"\u0000*\u0000epage\";s:3:\"702\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-4551\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PIEDBOIS\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:19:\"THOMAS-DELECOURT, F\";i:1;s:10:\"FLINOIS, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BUCABS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"\u00c9tude pharmaco\u00e9pid\u00e9miologique sur l'utilisation de fulvestrant en pratique clinique en France\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"\u00c9tude pharmaco\u00e9pid\u00e9miologique sur l'utilisation de fulvestrant en pratique clinique en France\";s:9:\"\u0000*\u0000jtitle\";s:18:\"Bulletin du cancer\";s:9:\"\u0000*\u0000stitle\";s:12:\"Bull. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"695\";s:8:\"\u0000*\u0000epage\";s:3:\"702\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-4551\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PIEDBOIS\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:19:\"THOMAS-DELECOURT, F\";i:1;s:10:\"FLINOIS, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BUCABS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"\u00c9tude pharmaco\u00e9pid\u00e9miologique sur l'utilisation de fulvestrant en pratique clinique en France\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
